A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data.

In silico prediction of drug-target interactions from heterogeneous biological data can advance our system-level search for drug molecules and therapeutic targets, which efforts have not yet reached full fruition. In this work, we report a systematic approach that efficiently integrates the chemical...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hua Yu, Jianxin Chen, Xue Xu, Yan Li, Huihui Zhao, Yupeng Fang, Xiuxiu Li, Wei Zhou, Wei Wang, Yonghua Wang
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ea40cb89e25b401ab9039e278c05af95
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ea40cb89e25b401ab9039e278c05af95
record_format dspace
spelling oai:doaj.org-article:ea40cb89e25b401ab9039e278c05af952021-11-18T07:16:58ZA systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data.1932-620310.1371/journal.pone.0037608https://doaj.org/article/ea40cb89e25b401ab9039e278c05af952012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22666371/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203In silico prediction of drug-target interactions from heterogeneous biological data can advance our system-level search for drug molecules and therapeutic targets, which efforts have not yet reached full fruition. In this work, we report a systematic approach that efficiently integrates the chemical, genomic, and pharmacological information for drug targeting and discovery on a large scale, based on two powerful methods of Random Forest (RF) and Support Vector Machine (SVM). The performance of the derived models was evaluated and verified with internally five-fold cross-validation and four external independent validations. The optimal models show impressive performance of prediction for drug-target interactions, with a concordance of 82.83%, a sensitivity of 81.33%, and a specificity of 93.62%, respectively. The consistence of the performances of the RF and SVM models demonstrates the reliability and robustness of the obtained models. In addition, the validated models were employed to systematically predict known/unknown drugs and targets involving the enzymes, ion channels, GPCRs, and nuclear receptors, which can be further mapped to functional ontologies such as target-disease associations and target-target interaction networks. This approach is expected to help fill the existing gap between chemical genomics and network pharmacology and thus accelerate the drug discovery processes.Hua YuJianxin ChenXue XuYan LiHuihui ZhaoYupeng FangXiuxiu LiWei ZhouWei WangYonghua WangPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 5, p e37608 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hua Yu
Jianxin Chen
Xue Xu
Yan Li
Huihui Zhao
Yupeng Fang
Xiuxiu Li
Wei Zhou
Wei Wang
Yonghua Wang
A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data.
description In silico prediction of drug-target interactions from heterogeneous biological data can advance our system-level search for drug molecules and therapeutic targets, which efforts have not yet reached full fruition. In this work, we report a systematic approach that efficiently integrates the chemical, genomic, and pharmacological information for drug targeting and discovery on a large scale, based on two powerful methods of Random Forest (RF) and Support Vector Machine (SVM). The performance of the derived models was evaluated and verified with internally five-fold cross-validation and four external independent validations. The optimal models show impressive performance of prediction for drug-target interactions, with a concordance of 82.83%, a sensitivity of 81.33%, and a specificity of 93.62%, respectively. The consistence of the performances of the RF and SVM models demonstrates the reliability and robustness of the obtained models. In addition, the validated models were employed to systematically predict known/unknown drugs and targets involving the enzymes, ion channels, GPCRs, and nuclear receptors, which can be further mapped to functional ontologies such as target-disease associations and target-target interaction networks. This approach is expected to help fill the existing gap between chemical genomics and network pharmacology and thus accelerate the drug discovery processes.
format article
author Hua Yu
Jianxin Chen
Xue Xu
Yan Li
Huihui Zhao
Yupeng Fang
Xiuxiu Li
Wei Zhou
Wei Wang
Yonghua Wang
author_facet Hua Yu
Jianxin Chen
Xue Xu
Yan Li
Huihui Zhao
Yupeng Fang
Xiuxiu Li
Wei Zhou
Wei Wang
Yonghua Wang
author_sort Hua Yu
title A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data.
title_short A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data.
title_full A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data.
title_fullStr A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data.
title_full_unstemmed A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data.
title_sort systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/ea40cb89e25b401ab9039e278c05af95
work_keys_str_mv AT huayu asystematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
AT jianxinchen asystematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
AT xuexu asystematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
AT yanli asystematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
AT huihuizhao asystematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
AT yupengfang asystematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
AT xiuxiuli asystematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
AT weizhou asystematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
AT weiwang asystematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
AT yonghuawang asystematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
AT huayu systematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
AT jianxinchen systematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
AT xuexu systematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
AT yanli systematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
AT huihuizhao systematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
AT yupengfang systematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
AT xiuxiuli systematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
AT weizhou systematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
AT weiwang systematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
AT yonghuawang systematicpredictionofmultipledrugtargetinteractionsfromchemicalgenomicandpharmacologicaldata
_version_ 1718423699365822464